The Agency for Healthcare Research and Quality has awarded a $12 million grant to Cincinnati Children's Hospital Medical Center for the creation of an inflammatory bowel diseases (IBD) registry that ...

SOUTH SAN FRANCISCO, Calif. & NEW YORK--(BUSINESS WIRE)--Verily, an Alphabet company focused on precision health, and the Crohn’s & Colitis Foundation, a non-profit organization dedicated to finding ...

The Crohn's & Colitis Foundation and an international consortium of leading IBD researchers, today announced the launch of the Global IBD Registry (GLIDE), a pioneering initiative designed to securely ...

Verily is on the up-and-up—as in, re-upping a team-up with the Crohn’s & Colitis Foundation to help spur research into inflammatory bowel disease (IBD) forward. Alphabet’s life sciences arm announced ...

WALTHAM, Mass., Sept. 29, 2022 /PRNewswire/ -- CorEvitas, LLC, the leading sponsor of registries in autoimmune and inflammatory diseases, is pleased to announce its inflammatory bowel disease (IBD) ...

More than 40,000 inflammatory bowel disease patients are coming together to join a new IBD registry. Here are four things to know about the Crohn’s & Colitis Foundation of America’s newest research ...

New York, NY –September 22, 2025 – The Crohn’s & Colitis Foundation and an international consortium of leading IBD researchers, today announced the launch of the Global IBD Registry (GLIDE), a ...

Cincinnati Children’s Hospital has received a $12 million grant to create a registry system aimed at improving outcomes for patients with inflammatory bowel disease, according to the organization’s ...

A discrete choice experiment (DCE) revealed no meaningful difference in preference between dual biologic therapy (DBT) or monotherapy among patients with inflammatory bowel disease (IBD) who had ...